menu search

MDGEF / Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)
Martinsried /M unich , April 27 , 202 3 . Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, will be presenting at the 20th Association for Cancer Immunotherapy (CIMT) annual meeting being held on May 3-5, 2023, in Mainz. Read More
Posted: Apr 27 2023, 05:00
Author Name: GlobeNewsWire
Views: 102189

MDGEF News  

Medigene AG to present at the Baader Investment Conference 2023

By GlobeNewsWire
September 11, 2023

Medigene AG to present at the Baader Investment Conference 2023

Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company f more_horizontal

Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference

By GlobeNewsWire
September 5, 2023

Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference

Planegg/Martinsried, September 5, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discove more_horizontal

Medigene AG to present at the 8th CAR-TCR Summit in Boston

By GlobeNewsWire
August 22, 2023

Medigene AG to present at the 8th CAR-TCR Summit in Boston

Planegg/ Martins ried , August 22 , 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the disco more_horizontal

Medigene AG to present at upcoming investor conferences

By GlobeNewsWire
May 8, 2023

Medigene AG to present at upcoming investor conferences

Planegg/Martinsried, May 8, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and more_horizontal

Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

By GlobeNewsWire
April 27, 2023

Medigene AG to Present Expitope 3.0 at the 20th Annual Meeting of the Association for Cancer Immunotherapy (CIMT)

Martinsried /M unich , April 27 , 202 3 . Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the disco more_horizontal

Medigene AG (MDGEF) Management on H1 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 7, 2022

Medigene AG (MDGEF) Management on H1 2022 Results - Earnings Call Transcript

Medigene AG (OTCPK:MDGEF) H1 2022 Earnings Conference Call August 3, 2022 9:00 AM ET Company Participants Anna Niedl - Investor Relations Dolores Sche more_horizontal


Search within

Pages Search Results: